Personalis
Jill Williams is a seasoned professional in the biotechnology and molecular diagnostics field, currently serving as Senior Reagent Manager at Personalis, Inc. since January 2019, where responsibilities include establishing a reagent management framework for NGS workflows. Prior experience includes a role as Systems Manufacturing Manager at Takara Bio USA, Inc., focusing on high-throughput gene expression systems and NGS processes. This follows a tenure at WaferGen as Reagent Manufacturing Manager, contributing to the company's acquisition by Takara Bio. Jill's earlier career at Roche Molecular Systems involved leading manufacturing operations under GMP/FDA/ISO guidelines, while previous positions include Chemist III at Molecular Devices and Production Chemist at Bio-Rad Laboratories. Educational qualifications comprise a BS in Biology from California State University - East Bay and a Lean Six Sigma Green Belt Certification from UC San Diego Extended Studies.
Personalis
4 followers
Personalis is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA Million Veteran Program (MVP). In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis® ImmunoID NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP-aligned as well as CLIA’88-certified and CAP-accredited.